{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:13:40Z","timestamp":1784121220772,"version":"3.55.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[1998,9,1]],"date-time":"1998-09-01T00:00:00Z","timestamp":904608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1998,9,1]],"date-time":"1998-09-01T00:00:00Z","timestamp":904608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[1998,9]]},"DOI":"10.1136\/ard.57.9.545","type":"journal-article","created":{"date-parts":[[2008,12,6]],"date-time":"2008-12-06T00:32:33Z","timestamp":1228523553000},"page":"545-549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":211,"title":["Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout"],"prefix":"10.1016","volume":"57","author":[{"given":"F","family":"Perez-Ruiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Alonso-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Calabozo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Herrero-Beites","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Garc\u00eda-Erauskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Ruiz-Lucea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.57.9.545_bib1","series-title":"Textbook of the rheumatic diseases.","first-page":"249","article-title":"Gout.","author":"Cohen","year":"1948"},{"key":"10.1136\/ard.57.9.545_bib2","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/0002-9343(74)90634-2","article-title":"Milestones in the treatment of gout.","volume":"56","author":"Yu","year":"1974","journal-title":"Am J Med"},{"key":"10.1136\/ard.57.9.545_bib3","first-page":"89","article-title":"An approach to hyperuricemia and gout.","volume":"39","author":"Palella","year":"1984","journal-title":"Geriatrics"},{"key":"10.1136\/ard.57.9.545_bib4","series-title":"Arthritis and allied conditions.","first-page":"1677","article-title":"Management of hyperuricemia.","author":"Wortmann","year":"1989"},{"key":"10.1136\/ard.57.9.545_bib5","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0889-857X(21)00975-3","article-title":"Therapy in gout.","volume":"14","author":"Wallace","year":"1988","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1136\/ard.57.9.545_bib6","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0889-857X(21)01008-5","article-title":"Control of crystal-induced arthropathies.","volume":"15","author":"Diamond","year":"1989","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1136\/ard.57.9.545_bib7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0950-3579(05)80016-0","article-title":"Strategies and controversies in the treatment of gout and hyperuricemia.","volume":"4","author":"Fam","year":"1990","journal-title":"Baillieres Clin Rheumatol"},{"key":"10.1136\/ard.57.9.545_bib8","first-page":"1621","article-title":"Should patients with interval gout be treated with urate lowering drugs?","volume":"22","author":"Fam","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.57.9.545_bib9","doi-asserted-by":"crossref","first-page":"812","DOI":"10.7326\/0003-4819-90-5-812","article-title":"Management of gout.","volume":"90","author":"Simkin","year":"1979","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.57.9.545_bib10","first-page":"1618","article-title":"An evidence based appraisal of the management of nontophaceous interval gout.","volume":"22","author":"Ferraz","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.57.9.545_bib11","first-page":"908","article-title":"A cost effective analysis of urate lowering drugs in nontophaceous recurrent gouty arthritis.","volume":"22","author":"Ferraz","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.57.9.545_bib12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0889-857X(21)00376-8","article-title":"Treatment of refractory crystal- associated arthritis.","volume":"21","author":"Rosenthal","year":"1995","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1136\/ard.57.9.545_bib13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ard.42.Suppl_1.12","article-title":"Studies on crystallisation in relation to gout.","volume":"42 (suppl)","author":"Fiddis","year":"1983","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.57.9.545_bib14","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1002\/art.1780351024","article-title":"Reduce serum uric acid levels before withdrawing antihyperuricemic therapy in patients with tophaceous gout. [Letter].","volume":"35","author":"Gast","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.57.9.545_bib15","first-page":"1252","article-title":"[Reply to the letter to the editor].","volume":"35","author":"Mc Carthy","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.57.9.545_bib16","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1056\/NEJM199602153340707","article-title":"The management of gout.","volume":"334","author":"Emmerson","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.57.9.545_bib17","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/art.1780200320","article-title":"Preliminary criteria for the classification of the acute arthritis of primary gout.","volume":"20","author":"Wallace","year":"1977","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.57.9.545_bib18","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1136\/bmj.296.6637.1641-a","article-title":"Alcoholic response to treatment of gout.","volume":"296","author":"Ralston","year":"1988","journal-title":"BMJ"},{"key":"10.1136\/ard.57.9.545_bib19","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(72)92271-4","article-title":"Effect of weight-loss on plasma and urinary levels of uric acid.","volume":"ii","author":"Nichols","year":"1972","journal-title":"Lancet"},{"key":"10.1136\/ard.57.9.545_bib20","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0002-9343(88)80091-3","article-title":"Renal excretion of hypoxanthine and xanthine in primary gout.","volume":"85","author":"Garcia","year":"1988","journal-title":"Am J Med"},{"key":"10.1136\/ard.57.9.545_bib21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0002-9343(90)90097-W","article-title":"Uric acid handling in autosomal dominant polycystic kidney disease with normal filtration rates.","volume":"89","author":"Kaehny","year":"1990","journal-title":"Am J Med"},{"key":"10.1136\/ard.57.9.545_bib22","series-title":"Epi Info, version 6: a word processing, database, and statistics program for epidemiology on microcomputers.","author":"Dean","year":"1994"},{"key":"10.1136\/ard.57.9.545_bib23","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/art.1780341203","article-title":"Influence of antihyperuricemic therapy on the clinical and radiographic progression of gout.","volume":"34","author":"McCarthy","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.57.9.545_bib24","first-page":"1246","article-title":"Intermittent control of hyperuricemia in the treatment of gout.","volume":"16","author":"Bull","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.57.9.545_bib25","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1136\/ard.33.4.304","article-title":"Withdrawal of allopurinol in patients with gout.","volume":"33","author":"Loebl","year":"1974","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.57.9.545_bib26","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/art.1780270417","article-title":"Tophaceous gout: a clinical and radiographic assessment.","volume":"27","author":"Nakayama","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.57.9.545_bib27","first-page":"1383","article-title":"Withdrawal of longterm antihyperuricemic therapy in tophaceous gout.","volume":"20","author":"Lieshout-Zuidema","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.57.9.545_bib28","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/BF02201004","article-title":"Withdrawal of longterm antihyperuricemic therapy in tophaceous gout.","volume":"1","author":"Gast","year":"1987","journal-title":"Clin Rheumatol"},{"key":"10.1136\/ard.57.9.545_bib29","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1056\/NEJM197906283002604","article-title":"Hyperuricemia and gout.","volume":"300","author":"Boss","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.57.9.545_bib30","first-page":"1232","article-title":"The misdiagnosis of gout and hyperuricemia.","volume":"18","author":"Wolf","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.57.9.545_bib31","first-page":"1841","article-title":"A survey of current prescribing practices of antiinflammatory and urate lowering drugs in gouty arthritis in the province of Ontario.","volume":"15","author":"Bellamy","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.57.9.545_bib32","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/0895-4356(94)00244-K","article-title":"The prevalence and prophylaxis of gout in England.","volume":"48","author":"Harris","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"10.1136\/ard.57.9.545_bib33","series-title":"Arthritis and allied conditions.","first-page":"1645","article-title":"Clinical gout and the pathogenesis of hyperuricemia.","author":"Levinson","year":"1989"},{"key":"10.1136\/ard.57.9.545_bib34","series-title":"Rheumatology.","first-page":"7\/12.1","article-title":"Crystal arthropathies: gout.","author":"Cohen","year":"1994"},{"key":"10.1136\/ard.57.9.545_bib35","first-page":"S48","article-title":"Analysis of the methods for the classification of renal handling of urate in gout.","volume":"40 (suppl)","author":"Perez-Ruiz","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.57.9.545_bib36","first-page":"104","article-title":"Toxic hepatitis due to cincophen. Report of three cases. [English abstract].","volume":"97","author":"Cutrin","year":"1991","journal-title":"Med Clin (Barc)"},{"key":"10.1136\/ard.57.9.545_bib37","first-page":"437","article-title":"The pharmacology of hypouricemic effect of benzbromarone.","volume":"2","author":"Sinclair","year":"1974","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.57.9.545_bib38","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/art.1780190209","article-title":"Clinical evaluation of benzbromarone. A new uricosuric drug.","volume":"19","author":"Sorensen","year":"1976","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.57.9.545_bib39","first-page":"701","article-title":"Ten years' experience with benzbromarone in the management of gout.","volume":"59","author":"Masbernard","year":"1981","journal-title":"South Afr Med J"},{"key":"10.1136\/ard.57.9.545_bib40","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/ndt\/9.5.548","article-title":"Excellent uricosuric efficacy of benzbromarone in cyclosporin-A-treated renal transplant patients patients: a prospective study.","volume":"9","author":"Z\u00fcrcher","year":"1994","journal-title":"Nephrol Dial Transplant"},{"key":"10.1136\/ard.57.9.545_bib41","first-page":"412","article-title":"Uric acid stones.","volume":"5","author":"Asplin","year":"1996","journal-title":"Semin Nephrol"},{"key":"10.1136\/ard.57.9.545_bib42","first-page":"S86","article-title":"Allopurinol may have protective effect against acute gouty arthritis independent from its hypouricemic action.","volume":"39 suppl","author":"Bautler","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.57.9.545_bib43","series-title":"Anatomical therapeutic chemical (ATC) classification index. Including defined daily dosis (DDDs) for plain substances.","year":"1993"},{"key":"10.1136\/ard.57.9.545_bib44","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/art.1780290111","article-title":"The allopurinol hypersensitivity syndrome. Unnecessary morbidity and mortality.","volume":"29","author":"Singer","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.57.9.545_bib45","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0002-9343(84)90743-5","article-title":"Severe allopurinol toxicity: Description and guidelines for prescription in patients with renal insufficiency.","volume":"76","author":"Hande","year":"1984","journal-title":"Am J Med"},{"key":"10.1136\/ard.57.9.545_bib46","first-page":"1661","article-title":"Myelosuppression associated with azathioprine-allopurinol interaction after heart and lung transplantation.","volume":"61","author":"Cummings","year":"1996","journal-title":"Transplantation"},{"key":"10.1136\/ard.57.9.545_bib47","first-page":"16","article-title":"Biotransformation and uric acid lowering effect of benzbromarone in patients with liver cirrhosis - evidence for active benzbromarone metabolites?","volume":"1","author":"Walter-Sack","year":"1995","journal-title":"Eur J Med Res"},{"key":"10.1136\/ard.57.9.545_bib48","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0168-8278(94)80011-1","article-title":"Hepatic injury caused by benzbromarone.","volume":"20","author":"Van der Klauw","year":"1994","journal-title":"J Hepatol"},{"key":"10.1136\/ard.57.9.545_bib49","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0168-8278(05)80159-X","article-title":"Subfulminant hepatitis requiring liver transplantation after benzarone administration.","volume":"20","author":"Gehenot","year":"1994","journal-title":"J Hepatol"},{"key":"10.1136\/ard.57.9.545_bib50","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1600-0676.1995.tb00102.x","article-title":"Severe hepatotoxicity related to benzarone: report of three cases with two fatalities.","volume":"15","author":"Hautekeete","year":"1995","journal-title":"Liver"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724500000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724500000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.57.9.545","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T14:41:47Z","timestamp":1737556907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724500000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,9]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1998,9]]}},"alternative-id":["S0003496724500000"],"URL":"https:\/\/doi.org\/10.1136\/ard.57.9.545","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[1998,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.57.9.545","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1998 Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}